- Service Name
DaxibotulinumtoxinA for Injection (DAXXIFY)
- Industry
Biotechnology, Aesthetics, Therapeutics, Aesthetic Medicine
- Main Value Proposition
Revance offers innovative aesthetic solutions that enhance patient outcomes and physician experiences, backed by extensive research and development.
- Description
DaxibotulinumtoxinA for Injection is a neuromuscular blocking agent used for the temporary improvement of moderate to severe glabellar lines and for the treatment of cervical dystonia in adults. It is part of Revance's innovative aesthetic and therapeutic offerings aimed at enhancing patient and physician experiences.
- Key Features
Temporary improvement of glabellar lines; Treatment for cervical dystonia; Innovative formulation with a unique delivery system; Comprehensive support and resources for practices
- Use Cases
Aesthetic treatments for patients seeking to reduce the appearance of wrinkles; Management of cervical dystonia in adult patients; Support for aesthetic practices looking to enhance service offerings
- Competitive advantages
Proven efficacy in reducing glabellar lines and treating cervical dystonia; Strong support network for practice partners; Continuous investment in research and development leading to innovative products
- Strengths
Revance's strengths lie in its innovative product offerings, strong R&D backing, and commitment to enhancing patient and physician experiences.
- Positioning
Revance positions itself as a leader in the biotechnology industry, focusing on innovative solutions that improve healthcare outcomes.
- Audience
The primary audience includes aesthetic practices, healthcare providers, and adult patients seeking aesthetic improvements or treatment for cervical dystonia.
- CTA
Learn more about our products and explore opportunities.
- Tags
Aesthetic solutions
Therapeutics
Innovative healthcare
Patient satisfaction
- Tagline
Setting the new standard in healthcare.
- Tone of Voice
Professional, supportive, innovative
- Differentiation
Revance differentiates itself through its unique formulation of DaxibotulinumtoxinA, which provides longer-lasting results compared to traditional botulinum toxin products.
- Brand Positioning
Revance is identified as a forward-thinking biotechnology company dedicated to enhancing patient and physician experiences through innovative aesthetic and therapeutic solutions.
- Founded
2002-01-01
- Founders
Dan Browne
Jacob Waugh